Treatment of intractable oral lichen planus with intravenous immunoglobulin therapy.

ejd.2012.1827 Auteur(s) : Chisa Nakashima otsukamn@kuhp.kyoto-u.ac.jp, Atsushi Otsuka, Hiroko Sonobe, Akihiko Kitoh, Mayumi Kato, Satoshi Kore-Eda, Yoshiki Miyachi, Kenji Kabashima Department of Dermatology, Kyoto University School of Medicine, 54 Shogoin-Kawara Sakyo, Kyoto 606-8507, Japan Lichen planus (LP) is a chronic dermatosis and is idiopathic or associated with underlying systemic diseases, such as hepatitis C virus [1]. LP can involve skin, genital mucosa, hair follicles, and nails. In [...]

[1]  M. Gonçalo,et al.  Patch testing in fixed drug eruptions–a 20‐year review , 2011, Contact dermatitis.

[2]  P. Friedmann,et al.  Patch testing in drug allergy , 2010, Current opinion in allergy and clinical immunology.

[3]  A. Carlucci,et al.  Study of In Vitro Drug Release and Percutaneous Absorption of Fluconazole from Topical Dosage Forms , 2010, AAPS PharmSciTech.

[4]  A. Barbaud,et al.  Negative predictive value of drug skin tests in investigating cutaneous adverse drug reactions , 2007, The British journal of dermatology.

[5]  M. Schaller,et al.  A young woman with recurrent vesicles on the lower lip: fixed drug eruption mimicking herpes simplex. , 2008, Acta dermato-venereologica.

[6]  K. Timonen,et al.  Fixed drug eruption due to fluconazole. , 2000, Journal of the American Academy of Dermatology.